Products with Precursors bioactivity
| Cat.No. | Product Name |
|---|---|
| BCN4900 | Sinapaldehyde |
| 1. Sinapaldehyde has effects against 65 strains of Candida . 2. The reaction of sinapaldehyde and methylpyranoanthocyanin can obtain a new bluish pigment. 3. Sinapaldehyde inhibits prostaglandin synthetase in a dose-dependent way, it dose-dependently inhibits ethyl phenylpropiolate-induced edema of the rat ear, and can inhibit electrically induced contractions of the guinea pig ileum in a dose-dependent way. | |
| BCN5085 | 7-Isopentenyloxy-gamma-fagarine |
| 1. 7-Isopentenyloxy-gamma-fagarine has highly cytotoxicity against the MCF-7and Jurkat cell line. 2. 7-Isopentenyloxy-gamma-fagarine, has been used as a precursor for the chemical asymmetric synthesis of the enantiopure alkaloids: evoxine, anhydroevoxine and evodine. | |
| BCN5088 | Vomifoliol |
| 1. Vomifoliol is most likely the immediate precursor of dehydrovomifoliol, because of the organism converted abscisic acid (ABA), to dehydrovomifoliol as the major metabolise, and a cell-free extract exhibits vomifoliol dehydrogenase activity. 2. Vomifoliol and stigmasterol have anti-proliferative activity on human lung cancer cell lines. | |
| BCN5126 | Preisocalamendiol |
| 1. Preisocalamendiol, a plausible precursor of isocalamendiol. | |
| BCN5158 | Lariciresinol |
| 1. Dietary lariciresinol can attenuate mammary tumor growth and reduce blood vessel density in human MCF-7 breast cancer xenografts and carcinogen-induced mammary tumors in rats. 2. Lariciresinol is an enterolignan precursor, it possesses fungicidal activities by disrupting the fungal plasma membrane and therapeutic potential as a novel antifungal agent for the treatment of fungal infectious diseases in humans. | |
